The relevance of K i calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor

European Journal of Medicinal Chemistry
2017.0

Abstract

Histone acetyltransferases (HATs) are important mediators of epigenetic post-translational modifications of histones that play important roles in health and disease. A disturbance of these modifications can result in disease states, such as cancer or inflammatory diseases. Inhibitors of HATs (HATi) such as lysine (K) acetyltransferase 8 (KAT8), could be used to study the epigenetic processes in diseases related to these enzymes or to investigate HATs as therapeutic targets. However, the development of HATi is challenged by the difficulties in kinetic characterization of HAT enzymes and their inhibitors to enable calculation of a reproducible inhibitory potency. In this study, a fragment screening approach was used, enabling identification of 4-amino-1-naphthol, which potently inhibited KAT8. The inhibitor was investigated for enzyme inhibition using kinetic and calorimetric binding studies. This allowed for calculation of the Ki values for both the free enzyme as well as the acetylated intermediate. Importantly, it revealed a striking difference in binding affinity between the acetylated enzyme and the free enzyme, which could not be revealed by the IC50 value. This shows that kinetic characterization of inhibitors and calculation of Ki values is crucial for determining the binding constants of HAT inhibitors. We anticipate that more comprehensive characterization of enzyme inhibition, as described here, is needed to advance the field of HAT inhibitors.

Knowledge Graph

Similar Paper

The relevance of K i calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor
European Journal of Medicinal Chemistry 2017.0
A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action
MedChemComm 2015.0
Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60
Bioorganic & Medicinal Chemistry 2009.0
Structural Insight into the Inhibition of Human Kynurenine Aminotransferase I/Glutamine Transaminase K
Journal of Medicinal Chemistry 2009.0
Design of species- or isozyme-specific enzyme inhibitors. 3. Species and isozymic differences between mammalian and bacterial adenylate kinases in substituent tolerance in an enzyme-substrate complex
Journal of Medicinal Chemistry 1979.0
A Novel Cell-Permeable, Selective, and Noncompetitive Inhibitor of KAT3 Histone Acetyltransferases from a Combined Molecular Pruning/Classical Isosterism Approach
Journal of Medicinal Chemistry 2015.0
Small-Molecule Inhibitors of Histone Acetyltransferase Activity:  Identification and Biological Properties
Journal of Medicinal Chemistry 2006.0
Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening
European Journal of Medicinal Chemistry 2018.0
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs)
Bioorganic & Medicinal Chemistry 2011.0
Structural, Mutagenic, and Kinetic Analysis of the Binding of Substrates and Inhibitors of Human PhenylethanolamineN-Methyltransferase
Journal of Medicinal Chemistry 2005.0